Skip to main content
. Author manuscript; available in PMC: 2017 Aug 15.
Published in final edited form as: Cancer Res. 2016 Jun 14;76(16):4741–4751. doi: 10.1158/0008-5472.CAN-15-3367

Table 1.

Clinical Covariates for miR-196b and miR-34c-5p Methylation Analysis in Sputum

Covariates Cases (N=82) Controls (N=162) p-Value1
Sex N (%) N (%) 0.71
 Male 63 (77) 121 (75)
 Female 19 (23)   41 (25)
Age (Years) 0.91
 Mean ± SD     65 ± 7.6     65 ± 7.3
 Range 45, 80 46, 76
Race2 N (%) N (%) 0.66
 Non-Hispanic White 57 (70) 117 (72)
 Hispanic 20 (24)   40 (25)
 Other 5 (6) 5 (3)
Smoking Status N (%) N (%) 0.80
 Current 27 (33)   56 (35)
 Former 55 (67) 106 (65)
Pack Years 0.27
 Mean ± SD     56 ± 30.6     52 ± 26.5
Lung Cancer Stage N (%)
 I 49 (60)
 II 11 (13)
 III 22 (27)
Histology N (%)
 Squamous Cell 30 (36)
 Adenocarcinoma 40 (49)
 NSCLC 8 (10)
 Other 4 (5)
1

Differences in covariates between cases and controls were assessed using Chi-square for categorical variables and Wilcoxon rank-sum test for continuous variables.

2

Race was dichotomized to non-Hispanic white and other.